Illumina (ILMN) Competitors $96.14 -1.79 (-1.83%) Closing price 04:00 PM EasternExtended Trading$96.71 +0.57 (+0.59%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment. Which has more volatility and risk, A or ILMN? Agilent Technologies has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Does the media refer more to A or ILMN? In the previous week, Agilent Technologies had 4 more articles in the media than Illumina. MarketBeat recorded 25 mentions for Agilent Technologies and 21 mentions for Illumina. Agilent Technologies' average media sentiment score of 0.99 beat Illumina's score of 0.59 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 17 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 12 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts prefer A or ILMN? Agilent Technologies currently has a consensus target price of $139.77, suggesting a potential upside of 22.64%. Illumina has a consensus target price of $125.11, suggesting a potential upside of 30.13%. Given Illumina's higher probable upside, analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54Illumina 2 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.40 Do institutionals and insiders hold more shares of A or ILMN? 89.4% of Illumina shares are owned by institutional investors. 2.6% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B4.97$1.29B$4.0528.14Illumina$4.37B3.48-$1.22B-$6.07-15.84 Is A or ILMN more profitable? Agilent Technologies has a net margin of 17.59% compared to Illumina's net margin of -22.25%. Agilent Technologies' return on equity of 25.92% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies17.59% 25.92% 13.24% Illumina -22.25%25.54%8.62% SummaryAgilent Technologies beats Illumina on 11 of the 17 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.22B$2.92B$5.49B$9.41BDividend YieldN/A2.45%3.80%4.04%P/E Ratio-15.8419.8828.0419.84Price / Sales3.48305.89431.4199.63Price / Cash20.6743.1635.8457.94Price / Book6.437.678.125.65Net Income-$1.22B-$55.28M$3.25B$258.00M7 Day Performance-3.13%2.50%0.97%2.09%1 Month Performance6.51%11.70%7.36%11.13%1 Year Performance-16.97%4.89%31.31%18.40% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.8519 of 5 stars$96.14-1.8%$125.11+30.1%-18.3%$15.22B$4.37B-15.849,030Analyst RevisionAAgilent Technologies4.7211 of 5 stars$120.10-2.6%$139.77+16.4%-12.8%$34.12B$6.51B29.6517,900MTDMettler-Toledo International4.1383 of 5 stars$1,195.06-2.4%$1,280.90+7.2%-12.5%$24.84B$3.83B29.8017,300Positive NewsWATWaters4.884 of 5 stars$303.93-13.9%$388.94+28.0%-5.4%$18.09B$2.98B27.587,600Trending NewsAnalyst DowngradeAnalyst RevisionHigh Trading VolumeTECHBio-Techne4.8726 of 5 stars$52.62-2.8%$70.00+33.0%-31.9%$8.25B$1.16B64.173,100Analyst RevisionCRLCharles River Laboratories International4.7629 of 5 stars$158.09-0.8%$174.54+10.4%-29.7%$7.77B$4.05B-243.2120,100BIOBio-Rad Laboratories4.6326 of 5 stars$250.92-2.4%$324.25+29.2%-21.6%$6.83B$2.54B-3.297,700BRKRBruker4.9753 of 5 stars$43.21-1.3%$52.89+22.4%-34.2%$6.55B$3.37B83.1011,396Positive NewsAnalyst RevisionPACBPacific Biosciences of California1.8719 of 5 stars$1.46-0.7%$2.06+41.2%-32.2%$438.12M$154.01M-0.52730Positive NewsHBIOHarvard Bioscience4.2587 of 5 stars$0.43-3.2%$3.00+596.7%-86.9%$19.04M$91.40M-0.33490Gap UpTMOThermo Fisher Scientific4.9933 of 5 stars$425.44-2.2%$600.30+41.1%-23.4%$160.60B$42.90B24.95125,000Trending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
